Zephyrnet Logo

Mend Secures $15 Million Funding to Enhance Surgical Patients’ Healing with Nutrapharma and Ongoing Care

Date:

Mend, a digital health platform that provides post-surgical care to patients, has secured $15 million in funding to enhance surgical patients’ healing with Nutrapharma and ongoing care. The funding round was led by Olive Tree Ventures, with participation from other investors, including Harel Insurance and Meitav Dash.

Mend’s platform is designed to help patients recover from surgery by providing personalized care plans, remote monitoring, and access to healthcare professionals. The platform uses artificial intelligence (AI) and machine learning (ML) algorithms to analyze patient data and provide personalized recommendations for recovery.

The new funding will be used to expand Mend’s services and partnerships, including a collaboration with Nutrapharma, a company that develops nutritional supplements for surgical patients. The partnership will allow Mend to offer personalized nutrition plans to patients, based on their specific needs and medical history.

In addition to the partnership with Nutrapharma, Mend will also use the funding to expand its network of healthcare providers and improve its technology platform. The company plans to hire additional staff, including data scientists and engineers, to help develop new features and improve the user experience.

Mend’s platform has already been used by thousands of patients, with positive results. According to the company, patients who use the platform have a lower risk of complications and readmissions, and they recover faster than those who do not use the platform.

The new funding will allow Mend to reach even more patients and provide them with the support they need to recover from surgery. The company’s focus on personalized care and ongoing support is a promising development in the field of digital health, where many platforms focus on one-time interventions rather than ongoing care.

Overall, Mend’s $15 million funding round is a significant milestone for the company and for the field of digital health. With the support of investors and partners like Nutrapharma, Mend is well-positioned to continue improving surgical patients’ healing and recovery.

spot_img

Latest Intelligence

spot_img